全球中央靜脈導管市場：市場規模、佔有率和趨勢分析（2025-2032 年）

全球中央靜脈導管市場報告（至2032年）

2025年全球中央靜脈導管市場價值為10億美元。預計到2032年，該市場將以1.4%的複合年成長率成長，達到11億美元。

本報告涵蓋全球中央靜脈導管（CVC）市場，包括急性期和慢性期護理應用。這兩類導管均包含電輸注型和非電輸注型裝置。

分析包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長主要受人口因素、慢性病負擔加重以及高壓輸注中心靜脈導管（CVC）應用日益普及的推動。然而，來自經周邊靜脈置入中央靜脈導管（PICC）的競爭以及CVC使用相關的高感染率仍然限制市場的進一步成長。

市場概覽

全球中心靜脈導管市場包括為藥物輸注、化療、靜脈營養、透析相關照護、重症監護和長期治療提供中心靜脈通路的裝置。

本市場涵蓋急性中心靜脈導管（CVC）和慢性中心靜脈導管。急性CVC通常用於短期住院和重症監護環境，而慢性CVC則用於滿足長期治療需求。急性CVC和慢性CVC均包含可在高壓下輸注的裝置和不能在高壓下輸注的裝置。

高壓注射式中心靜脈導管（CVC）已成為市場主流，並持續引領價值趨勢。對於靜脈通路受限的患者以及需要與造影增強成像相容的醫療機構而言，這些器械越來越受到青睞。

由於高壓注射式中心靜脈導管（CVC）在總安裝量中佔比很高，其較高的價格區間有助於維持平均售價（ASP）的穩定，並促進市場整體價值的成長。這一點至關重要，因為市場預計將逐步成長，而價值擴張更依賴產品組合的變化，而非銷售的顯著成長。

市場促進因素

人口統計因素

人口因素持續支撐著對中央靜脈導管的需求。全球人口正以每年約0.88%的速度成長，這導致需要住院、靜脈輸液和重症監護的患者群體不斷擴大。

雖然中心靜脈導管（CVC）可植入各年齡層的患者，但在老年患者和兒童患者中的使用更為頻繁。這些患者群體通常需要可靠的血管通路來進行複雜的治療、重症監護或長期治療。

隨著住院患者人數的增加以及更多患者需要接受高級治療，中心靜脈導管（CVC）市場的銷售額預計將會成長。儘管其他血管通路產品可能會限制市場的進一步擴張，但這龐大的患者群體支撐著穩定的需求。

慢性病負擔加重

慢性疾病負擔日益加重是中心靜脈導管（CVC）使用量成長的主要促進因素。癌症、需要透析的腎衰竭以及晚期心血管疾病發生率的上升，使得中心靜脈通路的需求持續存在。

中心靜脈導管（CVC）在化療、靜脈營養、長期用藥和重症監護中發揮著至關重要的作用。這些應用需要可靠的通路和高流速，而其他類型的裝置有時可能無法滿足這些要求。

隨著全球慢性疾病患者的增加，中心靜脈導管（CVC）的使用預計將穩定成長。這一因素在老化已開發市場和新興市場尤其重要，因為在這些市場，獲得先進治療的機會正在不斷改善。

採用高壓注射相容型中心靜脈導管

高壓注射相容型中心靜脈導管（CVC）的普及應用正在推動市場成長。這些導管設計用於承受更高的壓力，可用於造影增強成像工作流程。

對於靜脈通路受限的患者，高壓輸液相容型中心靜脈導管（CVC）因其能靈活滿足治療和影像檢查需求，正日益受到青睞。這減少了額外建立靜脈通路的需求，並提高了醫療效率。

由於高壓注射相容型中心靜脈導管的平均售價高於非高壓注射相容型導管，其日益普及有助於穩定整體平均價格。即使總銷售量成長緩慢，這也有助於市場規模的擴大。

市場限制

使用周邊置入的中央靜脈導管（PICC）

周邊置入中央靜脈導管（PICC）的使用限制了中心靜脈導管（CVC）市場的成長。在門診環境中，PICC的感染率顯著低於CVC，可用於許多類似的病例。

此外，由於PICC導管可由護理人員在床邊置入，這不僅降低了成本，也減輕了護理人員在操作過程中的負擔。因此，對於需要中心靜脈通路但不需要CVC高流量輸液的患者而言，PICC導管是相當吸引人的選擇。

然而，由於中心靜脈導管（CVC）的流速高於經周邊靜脈置入中心靜脈導管（PICC），因此在重症監護中仍然至關重要。在慢性病照護中，CVC預計將面臨PICC的競爭，通常會提前移除，並被PICC（在某些情況下甚至是周邊靜脈置入中心靜脈導管，PIVC）所取代。

感染率高

與其他導管相比，中心靜脈導管（CVC）的感染率較高。導管相關感染帶來的經濟成本和不良患者預後是嚴重限制CVC使用的主要因素。

只要條件允許，醫生傾向於選擇感染率低的導管。這可能會改變對PICC導管和其他靜脈通路裝置的需求（在臨床適用的情況下）。

雖然抗菌型中心靜脈導管（CVC）在一定程度上解決了這個問題，但CVC仍然是目前使用中最容易感染的導管之一。這種感染風險將持續影響急性和慢性照護機構中導管的選擇、照護方案和使用率。

培訓及實施注意事項

中心靜脈導管（CVC）置入需要具備相應的臨床技能、無菌技術和持續的導管管理。置入或維護不當會增加併發症的風險，包括感染疾病和血栓症。

隨著新型中心靜脈導管（CVC）技術的上市，訓練的重要性日益凸顯。對於高壓輸液裝置、抗菌導管以及其他特殊配置的產品，醫護人員必須熟悉其使用方法，以確保正確使用。

這些要求可能會限制缺乏受過訓練的人員或血管通路資源有限的醫療機構採用此類產品。在新興市場，培訓和基礎設施的缺乏可能會延緩高階中心靜脈導管產品的普及。

市場覆蓋範圍和數據範圍

• 定量範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
• 定性範圍：市場促進因素和限制因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
• 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
• 建立市場模型：收入分析採用銷售量和平均售價（ASP），並輔以治療量、競爭市場佔有率分析和預測假設。
• 目標器械：本報告涵蓋中央靜脈導管，包括急性中心靜脈導管和慢性中心靜脈導管。這兩類導管均包括高壓輸注相容型和非高壓輸注相容型器械。

目標市場及區隔

中央靜脈導管市場

• 設備類型：適用於急性和慢性疾病。

急性期中心靜脈導管主要用於醫院和重症監護室等需要短期中心靜脈通路的地方。這些裝置可支援藥物輸注、液體輸注、血流動力學監測以及其他需要可靠中心靜脈通路的護理需求。

當需要長期留置靜脈通路時，例如化療、靜脈營養或長期給藥，會使用慢性中心靜脈導管（CVC）。對於需要長期或反覆留置靜脈通路的患者來說，這些裝置至關重要。

適用於急性和慢性疾病的高壓輸注型中心靜脈導管 (CVC) 均有供應。這些導管支援高壓造影劑輸注，在需要與影像工作流程相容的醫療機構中越來越受歡迎。

非高壓輸注中心靜脈導管仍是市場上滿足標準中心靜脈通路需求的一部分。它們可用於對成本要求較高的環境或不需要高壓輸注的情況。

每個細分市場都按市場規模、市場佔有率、治療數量、市場預測、市場成長率、銷售量和平均售價進行分析。

競爭分析

2025年，泰利福在全球中心靜脈導管市場佔主導地位，在急性和慢性疾病領域均擁有主導市場佔有率。該公司的領先地位源於2007年對Arrow International的收購，此次收購使其獲得了全面的導管產品系列。

泰利福於2013年以其ARROW® JACC產品進軍慢性中心靜脈導管（CVC）市場。本產品採用Chlorag+ard®技術，具有抗菌和抗血栓特性，適用於短期和長期使用。泰利福主要代理三腔CVC產品，並報告稱，在CVC銷售額不斷成長的推動下，公司業績實現了強勁成長。

貝克頓·迪金森公司（Becton Dickinson）在2025年中心靜脈導管（CVC）市場排名中排名第二，這主要得益於其在慢性CVC領域的領先地位。 BD旗下品牌包括PowerHohn®、Hohn®、PowerLine®、PowerHickman®和Hickman® Trifusion®導管。

這些品牌已與慢性心血管疾病緊密聯繫起來。儘管慢性心血管疾病市場的成長率呈下降趨勢，但BD憑藉其穩固的市場地位和品牌知名度，仍佔著較大的市場佔有率。

透過主要專注於急性 CVC 領域，B. Braun 已確保到 2025 年在整個 CVC 市場佔第三大地位。其 Certofix® 和 Cavafix® 產品線支援此地位，而憑藉 Certofix® Protect 產品線，B. Braun 也在快速成長的抗菌導管領域具有競爭力。

技術和臨床趨勢

可注射式中心靜脈導管的普及

可注射式中心靜脈導管在市場上的影響力日益增強。這些裝置支援造影增強成像，是既需要中心靜脈通路又需要影像檢查的患者的首選。

這些產品的平均售價（ASP）很高，即使銷售量成長緩慢，也能支撐其市場價值。

抗菌導管

抗菌中心靜脈導管是預防感染風險的重要措施。這些產品旨在減少導管相關感染，改善患者預後。

雖然它不能完全消除感染風險，但它有助於改善中心靜脈導管的臨床評估。

抗血栓

抗血栓中心靜脈導管技術旨在減少血栓形成及其相關併發症。這些特性在短期和長期使用中都非常重要。

採用 Chlorag+ard® 技術的 ARROW® JACC 等產品反映了這一趨勢。

慢性CVC的品牌認知度

慢性中心靜脈導管仍然與知名品牌緊密相關，尤其是在長期治療市場。品牌認知至關重要，因為醫生和醫院通常依賴值得信賴的產品來滿足其複雜的導管置入需求。

這使得擁有成熟產品系列的現有競爭對手獲得了優勢。

與PICC的競爭

在門診和慢性病照護領域，PICC導管仍與CVC導管競爭。由於PICC導管感染率較低且可在床邊置入，因此通常是頗具吸引力的替代方案。

由於需要更高的流速，中心靜脈導管在重症監護環境中仍扮演重要角色。

重點在於感染預防

感染預防仍然是中心靜脈導管臨床實踐的核心挑戰。醫院繼續關注無菌插入、導管維護、抗菌產品和更換流程。

這一趨勢將繼續影響產品開發和臨床應用的方向。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份報告的意義

• 目前全球中心靜脈導管市場規模有多大？預計到 2032 年將成長多少？
• 在整個預測期內，急性和慢性中心靜脈導管（CVC）領域觀察到了哪些趨勢？
• 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
• 高壓注塑相容型 CVC 在穩定平均售價 (ASP) 方面發揮什麼作用？
• 癌症、腎衰竭和心血管疾病的增加對中心靜脈導管（CVC）的使用有何影響？
• 儘管面臨 PICC 導管的競爭，為什麼 CVC 在重症監護中仍然很重要？
• 感染風險如何影響產品選擇和市場成長？
• 抗菌和抗血栓技術在中心靜脈導管（CVC）的應用中扮演什麼角色？
• 哪些公司在全球企業創投市場中處於領先地位？
• Teleflex、BD 和 B. Braun 在各種 CVC 類別中分別處於什麼位置，特別是急性護理、慢性護理、抗菌治療和高壓注射能力？

iData Research 的「全球中央靜脈導管市場報告」透過設備層級分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告可用於評估需求、與競爭對手進行基準比較、了解高壓輸液相容產品的滲透率，並協助您制定全球中心靜脈導管市場的產業計畫。

目錄

調查方法

• 步驟 1：專案啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 步驟 4：進行初步調查
• 步驟 5：調查與分析：建立基準估計值
• 步驟 6：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟 9：客戶回饋與市場監測

全球關稅的影響

中央靜脈導管市場

• 摘要整理
  • 全球中央靜脈導管市場概覽
  • 競爭分析
  • 目標程式
  • 目標市場
  • 目標區域
• 介紹
• 手術次數
  • 中央靜脈導管置入術整體流程
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 中央靜脈導管市場的整體規模
  • 急性中央靜脈導管市場
  • 慢性中央靜脈導管市場
• 促進因素和抑制因素
• 競爭性市佔率分析

Global Central Venous Catheter Market Report to 2032

The global central venous catheter market was valued at $1 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 1.4%, reaching $1.1 billion by 2032.

This report covers the global market for central venous catheters (CVCs), including acute and chronic CVCs. Both categories include power-injectable and non-power-injectable devices.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by demographic factors, the rising burden of chronic disease, and increasing adoption of power-injectable CVCs. However, competition from PICCs and the high infection rate associated with CVC use continue to limit stronger growth.

Market Overview

The global central venous catheter market includes devices used to provide central venous access for medication delivery, chemotherapy, parenteral nutrition, dialysis-related care, critical care treatment, and long-term therapy.

The market includes acute and chronic CVCs. Acute CVCs are generally used in short-term hospital and critical care settings, while chronic CVCs support longer-term treatment needs. Both acute and chronic categories include power-injectable and non-power-injectable devices.

Power-injectable CVCs have become a dominant feature of the market and continue to shape value dynamics. These devices are increasingly preferred for patients with difficult venous access and in care settings where compatibility with contrast-enhanced imaging is important.

As power-injectable CVCs represent a larger share of total placements, their higher price point supports ASP stability and contributes to overall market value growth. This is important because the market is expected to grow modestly, with value supported more by product mix than by strong unit expansion.

Market Drivers

Demographic Factors

Demographic factors continue to support demand for central venous catheters. The world population is increasing at approximately 0.88% per year, creating a larger overall patient base requiring hospital care, infusion therapy, and critical care support.

CVCs are placed in patients of all ages, but they are more frequently used in elderly and pediatric patients. These groups often require reliable vascular access for complex treatment pathways, intensive care, or longer-term therapy.

As hospitalizations rise and more patients require advanced treatment, the number of units sold in the CVC market is expected to increase. This demographic base supports stable demand, even though competing vascular access products may limit stronger market expansion.

Growing Burden of Chronic Diseases

The growing burden of chronic disease is a major driver of CVC utilization. Increasing incidence of cancer, renal failure requiring dialysis, and advanced cardiovascular conditions creates a sustained need for central venous access.

CVCs play an important role in chemotherapy, parenteral nutrition, long-term medication delivery, and critical care treatment. These applications require reliable access and higher flow rates that may not always be achievable with substitute devices.

As chronic disease populations expand globally, CVC utilization is expected to grow steadily. This driver is especially important in developed markets with aging populations and in emerging markets where access to advanced treatment is improving.

Power-Injectable CVC Adoption

Power-injectable CVC adoption is supporting market value growth. These devices are designed to withstand higher pressures and can be used in contrast-enhanced imaging workflows.

Power-injectable CVCs are increasingly preferred in patients with difficult venous access because they provide flexibility across treatment and imaging needs. This can reduce the need for additional access placement and improve care efficiency.

Because power-injectable CVCs carry higher ASPs than non-power-injectable devices, their increased penetration supports overall ASP stability. This helps the market grow in value even when total unit expansion remains moderate.

Market Limiters

Use of Peripherally Inserted Central Catheters

The use of peripherally inserted central catheters has limited growth in the CVC market. In outpatient settings, PICCs have significantly lower infection rates than CVCs and can be used in many of the same cases.

PICCs can also be placed by nurses at the bedside, lowering costs and reducing procedural burden. This makes them attractive for patients who require central access but do not need the higher flow rates provided by CVCs.

However, CVCs remain indispensable in critical care because they offer higher flow rates than PICCs. In chronic care, CVCs are expected to face more competition from PICCs, and CVCs are often removed more quickly in order to be replaced with a PICC and then sometimes a PIVC.

High Infection Rate

CVCs have higher infection rates than substitute catheters. The financial costs and poor patient outcomes associated with catheter-related infections are strong limiters for CVC use.

Whenever possible, physicians prefer to place a catheter type with a lower infection rate. This can shift demand toward PICCs or other vascular access devices when clinically appropriate.

Antimicrobial CVCs partially address this issue, but CVCs will remain among the more infection-prone catheters in use. Infection risk will continue to influence device selection, care protocols, and adoption rates across both acute and chronic settings.

Training and Placement Considerations

CVC placement requires appropriate clinical skill, sterile technique, and ongoing catheter management. Improper placement or maintenance can increase the risk of complications, including infection and thrombosis.

As newer CVC technologies enter the market, training becomes even more important. Power-injectable devices, antimicrobial catheters, and specialized configurations may require staff familiarity to ensure correct use.

These requirements can limit adoption in facilities with fewer trained staff or limited vascular access resources. In emerging markets, training and infrastructure gaps may slow the adoption of premium CVC products.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers central venous catheters, including acute CVCs and chronic CVCs. Both categories include power-injectable and non-power-injectable devices.

Markets Covered and Segmentation

Central Venous Catheter Market

• Device type: Acute and chronic.

Acute CVCs are used primarily in hospital and critical care settings where short-term central venous access is needed. These devices support medication delivery, fluid administration, hemodynamic monitoring, and other care requirements where reliable central access is necessary.

Chronic CVCs are used for longer-term access needs, including chemotherapy, parenteral nutrition, and long-term medication delivery. These devices are important for patients who require repeated or extended access over time.

Power-injectable CVCs are available in both acute and chronic categories. These devices support high-pressure contrast injection and are increasingly preferred in care settings requiring compatibility with imaging workflows.

Non-power-injectable CVCs remain part of the market for standard central venous access needs. They may be used in cost-sensitive settings or when power injection is not required.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

Competitive Analysis

In 2025, Teleflex held the leading position in the global CVC market, dominating both the acute and chronic segments. Its leadership was established following the acquisition of Arrow International in 2007, which gave the company a comprehensive catheter product portfolio.

Teleflex entered the chronic CVC market in 2013 with the ARROW(R) JACC featuring Chlorag+ard(R) Technology, which offers antimicrobial and antithrombogenic properties suitable for both short-term and long-term use. The company primarily represents the triple-lumen subcategory of CVCs and has reported strong growth supported partly by increased CVC sales.

Becton Dickinson ranked as the second-leading competitor in the CVC market in 2025, largely due to its presence in the chronic CVC segment. BD's brands include PowerHohn(R), Hohn(R), PowerLine(R), PowerHickman(R), and Hickman(R) Trifusion(R) catheters.

These brands have become closely associated with chronic CVCs. Although the chronic CVC market has a declining growth rate, BD's established position and brand recognition support its significant market share.

B. Braun secured the third-leading position in the total CVC market in 2025 by focusing primarily on the acute CVC segment. Its Certofix(R) and Cavafix(R) product lines support its presence, while the Certofix(R) Protect line allows B. Braun to compete in the growing antimicrobial catheter segment.

Technology and Practice Trends

Power-Injectable CVC Penetration

Power-injectable CVCs are increasingly shaping market value. These devices support contrast-enhanced imaging and are preferred in patients who may require both central access and imaging compatibility.

Their higher ASPs support market value even when unit growth is modest.

Antimicrobial Catheters

Antimicrobial CVCs are an important response to infection risk. These products are designed to reduce catheter-related infections and improve patient outcomes.

Although they do not eliminate infection concerns, they help improve the clinical profile of CVCs.

Antithrombogenic Properties

Antithrombogenic CVC technologies are designed to reduce thrombus formation and related complications. These features may be important in both short-term and long-term use cases.

Products such as ARROW(R) JACC with Chlorag+ard(R) Technology reflect this trend.

Chronic CVC Brand Recognition

Chronic CVCs remain associated with established brands, especially in long-term therapy markets. Brand familiarity matters because physicians and hospitals often rely on trusted products for complex access needs.

This supports incumbent competitors with established portfolios.

PICC Competition

PICCs continue to compete with CVCs in outpatient and chronic care settings. Their lower infection rates and bedside placement advantages make them attractive substitutes in many cases.

CVCs remain important in critical care because of higher flow requirements.

Infection Prevention Focus

Infection prevention remains central to CVC practice. Hospitals continue to focus on sterile insertion, catheter maintenance, antimicrobial products, and replacement protocols.

This trend will continue shaping product development and clinical use.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global central venous catheter market today, and how much is it expected to grow through 2032?
• How are acute and chronic CVC segments performing across the forecast period?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• What role do power-injectable CVCs play in supporting ASP stability?
• How is the growing burden of cancer, renal failure, and cardiovascular disease affecting CVC utilization?
• Why do CVCs remain important in critical care despite competition from PICCs?
• How do infection risks affect product selection and market growth?
• What role do antimicrobial and antithrombogenic technologies play in CVC adoption?
• Which companies lead the global CVC market?
• How are Teleflex, BD, and B. Braun positioned across acute, chronic, antimicrobial, and power-injectable CVC categories?

The Global Central Venous Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand power-injectable adoption, and support commercial planning in the global CVC market.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Central Venous Catheter Market

• 6.1 Executive Summary
  • 6.1.1 Global Central Venous Catheter Market Overview
  • 6.1.2 Competitive Analysis
  • 6.1.3 Procedures Included
  • 6.1.4 Markets Included
  • 6.1.5 Regions Included
• 6.2 Introduction
• 6.3 Procedure Numbers
  • 6.3.1 Total Central Venous Catheter Procedures
    • 6.3.1.1 Acute Cvc Procedures
    • 6.3.1.2 Chronic Cvc Procedures
• 6.4 Market Overview
  • 6.4.1 By Segment
  • 6.4.2 By Region
• 6.5 Market Analysis And Forecast
  • 6.5.1 Total Central Venous Catheter Market
  • 6.5.2 Acute Central Venous Catheter Market
    • 6.5.2.1 Acute Power-Injectable Central Venous Catheter Market
    • 6.5.2.2 Acute Non-Power-Injectable Central Venous Catheter Market
  • 6.5.3 Chronic Central Venous Catheter Market
    • 6.5.3.1 Chronic Power-Injectable Central Venous Catheter Market
    • 6.5.3.2 Chronic Non-Power-Injectable Central Venous Catheter Market
• 6.6 Drivers And Limiters
  • 6.6.1 Market Drivers
  • 6.6.2 Market Limiters
• 6.7 Competitive Market Share Analysis

LIST OF CHARTS

• Chart 6-1: Central Venous Catheter Market, Global, 2025 & 2032
• Chart 6-2: Central Venous Catheter Procedures, Global, 2025
• Chart 6-3: Central Venous Catheter Procedures by Region, Global, 2022 - 2032
• Chart 6-4: Central Venous Catheter Market by Segment, Global, 2022 - 2032
• Chart 6-5: Central Venous Catheter Market by Region, Global, 2022 - 2032
• Chart 6-6: Leading Competitors, Central Venous Catheter Market, Global, 2025

LIST OF FIGURES

• Figure 6-1: Central Venous Catheter Procedures Covered
• Figure 6-2: Central Venous Catheter Markets Covered
• Figure 6-3: Central Venous Catheter Regions Covered, Global (1 of 2)
• Figure 6-4: Central Venous Catheter Regions Covered, Global (2 of 2)
• Figure 6-5: Central Venous Catheter Procedures by Region, Global, 2022 - 2032
• Figure 6-6: Central Venous Catheter Procedures by Country, North America, 2022 - 2032
• Figure 6-7: Central Venous Catheter Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-8: Central Venous Catheter Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-9: Central Venous Catheter Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-10: Central Venous Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-11: Central Venous Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-12: Central Venous Catheter Procedures by Country, Middle East, 2022 - 2032
• Figure 6-13: Central Venous Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-14: Central Venous Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-15: Central Venous Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-16: Central Venous Catheter Procedures by Country, Africa, 2022 - 2032
• Figure 6-17: Acute CVC Procedures by Region, Global, 2022 - 2032
• Figure 6-18: Acute CVC Procedures by Country, North America, 2022 - 2032
• Figure 6-19: Acute CVC Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-20: Acute CVC Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-21: Acute CVC Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-22: Acute CVC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-23: Acute CVC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-24: Acute CVC Procedures by Country, Middle East, 2022 - 2032
• Figure 6-25: Acute CVC Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-26: Acute CVC Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-27: Acute CVC Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-28: Acute CVC Procedures by Country, Africa, 2022 - 2032
• Figure 6-29: Chronic CVC Procedures by Region, Global, 2022 - 2032
• Figure 6-30: Chronic CVC Procedures by Country, North America, 2022 - 2032
• Figure 6-31: Chronic CVC Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-32: Chronic CVC Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-33: Chronic CVC Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-34: Chronic CVC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-35: Chronic CVC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-36: Chronic CVC Procedures by Country, Middle East, 2022 - 2032
• Figure 6-37: Chronic CVC Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-38: Chronic CVC Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-39: Chronic CVC Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-40: Chronic CVC Procedures by Country, Africa, 2022 - 2032
• Figure 6-41: Central Venous Catheter Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 6-42: Central Venous Catheter Market by Region, Global, 2022 - 2032 (US$M)
• Figure 6-43: Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-44: Units Sold by Region, Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-45: Average Selling Price by Region, Central Venous Catheter Market, Global, 2022 - 2032 (US$)
• Figure 6-46: Market Value by Region, Central Venous Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 6-47: Acute Central Venous Catheter Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 6-48: Total Acute Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-49: Units Sold by Region, Acute Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-50: Average Selling Price by Region, Acute Central Venous Catheter Market, Global, 2022 - 2032 (US$)
• Figure 6-51: Market Value by Region, Acute Central Venous Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 6-52: Acute Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-53: Units Sold by Region, Acute Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-54: Average Selling Price by Region, Acute Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$)
• Figure 6-55: Market Value by Region, Acute Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 6-56: Acute Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-57: Units Sold by Region, Acute Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-58: Average Selling Price by Region, Acute Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$)
• Figure 6-59: Market Value by Region, Acute Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 6-60: Chronic Central Venous Catheter Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 6-61: Total Chronic Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-62: Units Sold by Region, Chronic Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-63: Average Selling Price by Region, Chronic Central Venous Catheter Market, Global, 2022 - 2032 (US$)
• Figure 6-64: Market Value by Region, Chronic Central Venous Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 6-65: Chronic Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-66: Units Sold by Region, Chronic Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-67: Average Selling Price by Region, Chronic Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$)
• Figure 6-68: Market Value by Region, Chronic Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 6-69: Chronic Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-70: Units Sold by Region, Chronic Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032
• Figure 6-71: Average Selling Price by Region, Chronic Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$)
• Figure 6-72: Market Value by Region, Chronic Non-Power-Injectable Central Venous Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 6-73: Leading Competitors, Central Venous Catheter Market, Global, 2025